Exaggerated Language Causes Misunderstanding of Cancer Treatment Research

Language in oncology practice and research carries important implications. Most new drugs cannot cure disease completely, yet news describes them as “game-changing” or “breakthroughs”. Reaching wider audiences than medical journals, including patients, the public and investors, these reports become major information sources. Incomplete medical information and exaggerated descriptions can mislead readers.
Starting from this idea, the study investigated exaggerated (superlative) descriptions used in articles about cancer drugs. It aimed to identify the drug groups for which exaggerated expressions were used most frequently and the people using this language most often (journalists, doctors, patients and others).
“Breakthrough”, “game-changing”, “miracle”, “cure”, “successful”, “revolutionary”, “life-changing”, “lifesaving”, “groundbreaking” and “extraordinary”, a total of 10 cancer-drug-related superlatives, were searched on Google during 21-25 June 2015. The findings apply only to that period.
Among articles covering 36 drugs (3 unnamed), 94 articles contained 97 qualifying descriptions. Targeted therapies were commonest (% 47), followed by % 25 cytotoxic drugs, %14 checkpoint regulators and %8 cancer vaccines.
Across 94 articles, of 36 drugs, 18, half, were not FDA-approved. Journalists used most superlatives, followed by physicians (%55 journalists, % 27 physicians, % 9 experts, %8 patients).
The research found that superlative terms were used to describe many approved and unapproved cancer drugs. Targeted therapies were the drugs most frequently encountered in these articles, and the greatest number of superlatives appeared in these reports. Journalists were also found to use potentially misleading superlative language more often, despite not being experts in determining which cancer treatments are promising or how beneficial they might be. Such terms are very common in news about cancer research. It is therefore necessary to consider that some of them may be questionable.
As the study discussed in this article demonstrates, the way scientific data are expressed on public websites and in newspapers and magazines is extremely important. To avoid misleading patients and families who are constantly searching and selective in what they perceive, such expressions should be used only where they are truly deserved. Otherwise, the reports not only go beyond their purpose but cause disappointment among far more patients and family members than anticipated.
Sources
The Use of Superlatives in Cancer Research.
JAMA Oncol. 2015 Oct 29:1-2. doi: 10.1001/jamaoncol.2015.3931.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.